Filing Details

Accession Number:
0001618835-20-000203
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-06-18 16:29:37
Reporting Period:
2020-06-15
Accepted Time:
2020-06-18 16:29:37
Original Submission Date:
2020-06-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618835 Evofem Biosciences Inc. EVFM Pharmaceutical Preparations (2834) 208527075
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726731 Walmsley William Hall C/O Evofem Biosciences, Inc.
12400 High Bluff Drive, Suite 600
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-15 5,000 $2.85 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The original Form 4, filed on June 17,2020, is being amended to update the price range reported in Column 4 of Table I.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.845 to $2.85, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.